Inhibition of p53 DNA binding function by the MDM2 protein acidic domain

54Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MDM2 regulates p53 predominantly by promoting p53 ubiquitination. However, ubiquitination-independent mechanisms of MDM2 have also been implicated. Here we show that MDM2 inhibits p53 DNA binding activity in vitro and in vivo. MDM2 binding promotes p53 to adopt a mutant-like conformation, losing reactivity to antibody Pab1620, while exposing the Pab240 epitope. The acidic domain of MDM2 is required to induce p53 conformational change and inhibit p53 DNA binding. Alternate reading frame binding to the MDM2 acidic domain restores p53 wild type conformation and rescues DNA binding activity. Furthermore, histone methyl transferase SUV39H1 binding to the MDM2 acidic domain also restores p53 wild type conformation and allows p53-MDM2-SUV39H1 complex to bind DNA. These results provide further evidence for an ubiquitination-independent mechanism of p53 regulation by MDM2 and reveal how MDM2-interacting repressors gain access to p53 target promoters and repress transcription. Furthermore, we show that the MDM2 inhibitor Nutlin cooperates with the proteasome inhibitor Bortezomib by stimulating p53 DNA binding and transcriptional activity, providing a rationale for combination therapy using proteasome and MDM2 inhibitors. © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Cross, B., Chen, L., Cheng, Q., Li, B., Yuan, Z. M., & Chen, J. (2011). Inhibition of p53 DNA binding function by the MDM2 protein acidic domain. Journal of Biological Chemistry, 286(18), 16018–16029. https://doi.org/10.1074/jbc.M111.228981

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free